Abstract |
Recombinant feline interferon-omega preparation (rFeIFN-omega, trade name: INTERCAT) showed good clinical efficacy on canine parvovirus infection both in an experimental trial with beagles, and in field trials.
|
Authors | T Minagawa, K Ishiwata, T Kajimoto |
Journal | Veterinary microbiology
(Vet Microbiol)
Vol. 69
Issue 1-2
Pg. 51-3
(Sep 01 1999)
ISSN: 0378-1135 [Print] Netherlands |
PMID | 10515269
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Antiviral Agents
- Interferon Type I
- interferon omega 1
|
Topics |
- Animals
- Antiviral Agents
(therapeutic use)
- Cats
- Diarrhea
(complications, drug therapy)
- Dog Diseases
(drug therapy)
- Dogs
- Interferon Type I
(therapeutic use)
- Parvoviridae Infections
(complications, drug therapy, veterinary)
- Parvovirus, Canine
- Vomiting
(complications, drug therapy)
|